The purpose of this study is to determine the safety and effectiveness of the MorpheusV
Applicator for the treatment of overactive bladder (OAB) symptoms, including OAB, which has not
responded to other treatments. The procedure that you will undergo with the MorpheusV
Applicator uses radiofrequency heat to affect and possibly improve the functionality of the
abnormal nerve endings causing OAB.
You may qualify for this study if you:
Are female ages 22-80.
Have had symptoms of overactive bladder for at least 6 months.
Have a BMI less than 35.
Being part of this clinical trial is voluntary.
Eligible participants will receive all study-related care, procedures and medication at no cost. In addition, eligible participants may receive compensation for time and travel. No health insurance is required to participate.
For more information about this study, please call (316) 425-6333.